Major Announcements for Axplora
CDMO announces multi-million-euro investment to expand lyophilization and appoints Head of Site
Axplora, a global Contract Development and Manufacturing Organization (CDMO), is investing several million euros to enhance its lyophilization capabilities at its Le Mans facility in France. This expansion, set to commence in early 2027, is designed to address customer demands for efficient and reliable Antibody-Drug Conjugate (ADC) manufacturing. The move aims to streamline the handling of complex payloads while reducing risk and promoting operational excellence under the leadership of François Houbart, the newly appointed Head of Site.
1. Axplora invests in lyophilization in Le Mans, France. 2. Expansion aims to improve ADC manufacturing. 3. Launch of new capabilities expected in 2027. 4. François Houbart appointed as Head of Site. 5. Focus on operational excellence and quality. 6. Part of a €30m investment program. 7. Supports rapid ADC pipeline growth. 8. Reduces complexity and risk for customers.